Brief: New Data Suggest Entera’s Platform Orally Delivers Human Growth Hormone
06/04/2021 13:40
April 6 (Reuters) -
* NEW DATA SUGGEST ENTERA’S PLATFORM ORALLY DELIVERS HUMAN
GROWTH
HORMONE, STUDY RESULTS TO BE PRESENTED AT EUROPEAN PHARMA
CONGRESS
Source text for Eikon: ID:nGNX7zkPGR
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement